New Zealand markets closed

Enveric Biosciences Inc (SLZA.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.5800-0.0280 (-4.61%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
-
-
-
-
-
31,764
Gross profit
-
-
-
0
0
8,151
Operating expenses
Research development
8,627
7,252
8,028
4,789
174.083
-
Selling general and administrative
18,418
10,700
11,606
21,624
6,124
-
Total operating expenses
27,459
18,297
19,961
27,070
6,419
-
Operating income or loss
-27,459
-18,297
-19,961
-27,070
-6,419
-
Interest expense
10.239
-
5.249
10.316
445.25
691.138
Total other income/expenses net
-31,884
1,030
9.3
-29,352
-802.109
-
Income before tax
-59,354
-17,263
-19,957
-56,432
-6,865
-
Income tax expense
30.644
28.913
-1,486
-7,455
0
-
Income from continuing operations
-51,899
-17,292
-18,471
-48,977
-6,865
-
Net income
-51,919
-17,311
-18,504
-48,977
-6,865
-
Net income available to common shareholders
-52,104
-17,459
-18,800
-48,977
-6,865
-
Basic EPS
-11.51
-
-13.00
-103.69
-59.50
-566.00
Diluted EPS
-11.51
-
-13.00
-103.69
-59.50
-566.00
Basic average shares
2,109
-
1,446
472.343
115.071
10.644
Diluted average shares
2,109
-
1,446
472.343
115.071
10.644